SELECTA BIOSCIENCES INC - COM (RNAC) Institutional Ownership

CUSIP: 816212104

13F Institutional Holders and Ownership History from Q2 2016 to Q3 2024

Type / Class
Equity / COM
Symbol
RNAC on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 816212104?
CUSIP 816212104 identifies RNAC - SELECTA BIOSCIENCES INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of SELECTA BIOSCIENCES INC - COM (RNAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$11,105 0
2024 Q2 472 $11,105 -$34,729,197 $13.75 2
2024 Q1 53,463,914 $34,780,804 +$445,969 $0.65 60
2023 Q4 54,779,986 $37,769,668 +$684,634 $0.69 77
2023 Q3 53,955,165 $57,196,721 -$2,974,683 $1.06 82
2023 Q2 56,466,247 $63,240,073 +$9,257,052 $1.12 88
2023 Q1 46,813,988 $65,060,617 -$3,412,236 $1.39 90
2022 Q4 55,575,075 $62,800,441 -$4,494,020 $1.13 80
2022 Q3 62,568,793 $102,605,872 +$7,618,253 $1.64 90
2022 Q2 60,574,828 $79,336,551 -$5,565,548 $1.31 86
2022 Q1 57,788,317 $71,550,514 -$1,017,468 $1.23 96
2021 Q4 57,086,247 $185,688,590 +$4,510,285 $3.26 104
2021 Q3 51,903,403 $216,699,853 -$1,944,649 $4.16 101
2021 Q2 52,362,977 $219,157,722 -$8,489,955 $4.18 99
2021 Q1 54,172,006 $245,133,371 +$20,395,754 $4.52 94
2020 Q4 50,616,370 $153,383,148 -$14,400,142 $3.03 89
2020 Q3 55,696,891 $138,133,555 +$1,634,822 $2.48 74
2020 Q2 61,288,949 $174,055,693 +$17,559,511 $2.84 80
2020 Q1 56,504,375 $136,173,087 +$39,331,914 $2.41 59
2019 Q4 40,195,065 $94,994,086 +$51,556,368 $2.38 38
2019 Q3 18,513,110 $32,394,652 -$4,085,125 $1.75 35
2019 Q2 20,796,971 $37,264,804 -$3,013,675 $1.79 42
2019 Q1 22,243,271 $52,602,616 +$27,512,064 $2.37 53
2018 Q4 10,498,863 $27,995,801 -$9,367,592 $2.66 54
2018 Q3 11,428,823 $177,658,658 +$8,570,458 $15.55 65
2018 Q2 10,893,975 $144,342,395 +$10,887,800 $13.25 56
2018 Q1 10,263,686 $104,577,783 -$5,520,028 $10.19 58
2017 Q4 10,892,002 $106,854,606 -$21,762,805 $9.81 61
2017 Q3 12,155,444 $222,302,070 +$6,045,195 $18.25 53
2017 Q2 11,813,918 $234,607,229 +$80,033,083 $19.86 47
2017 Q1 8,630,957 $123,570,788 +$9,002,802 $14.32 44
2016 Q4 8,178,722 $140,260,111 +$5,033,101 $17.15 43
2016 Q3 7,446,999 $106,050,608 -$568,118 $14.25 28
2016 Q2 7,486,173 $104,734,000 +$104,734,000 $13.99 17